Raymond James Downgrades Amyris, Inc. (AMRS) to Outperform
Tweet
Share
E-mailGet Alerts AMRS Hot Sheet
Price: $9,454.42 --0%
Rating Summary:
4 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
4 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Raymond James downgraded Amyris, Inc. (NASDAQ: AMRS) from Strong Buy to Outperform, price target cut from $20 to $15.
For an analyst ratings summary and ratings history on Amyris, Inc. click here. For more ratings news on Amyris, Inc. click here.
Shares of Amyris, Inc. closed at $10.44 yesterday.
For an analyst ratings summary and ratings history on Amyris, Inc. click here. For more ratings news on Amyris, Inc. click here.
Shares of Amyris, Inc. closed at $10.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
